[Form 4] ANALOG DEVICES INC Insider Trading Activity

Rhea-AI Filing Summary

Analog Devices (ADI) Form 4: Chair & CEO Vincent Roche exercised 10,000 non-qualified stock options at $94.41 per share on 11/03/2025 and sold 10,000 common shares the same day at $234.95 per share pursuant to a 10b5-1 plan adopted on May 23, 2025.

After these transactions, he reported 163,640.462 shares held directly. He also reports 23,515 shares held indirectly by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024. Following the option exercise, 74,637 options remain beneficially owned. The exercised option was fully vested, originally exercisable from 03/15/2021 and expiring on 03/11/2030.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROCHE VINCENT

(Last) (First) (Middle)

ONE ANALOG WAY

(Street)

WILMINGTON MA 01887

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ANALOG DEVICES INC [ ADI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair & CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Comm Stock - $.16-2/3 value	11/03/2025		M		10,000	A	$94.41	173,640.462	D
Comm Stock - $.16-2/3 value	11/03/2025		S		10,000(1)	D	$234.95	163,640.462	D
Comm Stock-$.16-2/3 value								23,515	I(2)	Vincent Roche 2024 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$94.41	11/03/2025		M			10,000	03/15/2021(3)	03/11/2030	Comm Stock - $.16-2/3 value	10,000	$94.41	74,637	D

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan adopted by the Reporting Person on May 23, 2025.

2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.

3. This option is fully vested.

Remarks:

	/s/ Shelly Shaw, General Counsel, by Power of Attorney	11/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ADI’s CEO Vincent Roche report on this Form 4?

He exercised 10,000 options at $94.41 and sold 10,000 shares at $234.95 on 11/03/2025 under a 10b5-1 plan.

How many ADI shares does Vincent Roche own after the transactions?

He reported 163,640.462 shares held directly.

Does Vincent Roche have indirect ownership in ADI shares?

Yes. 23,515 shares are held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.

Were the sales made under a 10b5-1 plan for ADI (ADI)?

Yes. The sales were made pursuant to a 10b5-1 plan adopted on May 23, 2025.

What options remain after the exercise reported by ADI’s CEO?

He beneficially owns 74,637 options after exercising 10,000.

What are the key dates for the exercised option?

The option was fully vested, first exercisable on 03/15/2021 and expiring on 03/11/2030.